| CXHB0801681 | 注射用对甲苯磺酸二硫酸腺苷蛋氨酸 | Ademetionine disulfate tosylate | Lyophilized | Chemical Drugs | Supplementary Application | 2009-03-02 | 北京凯因科技股份有限公司 | Beijing Kawin Technology Share-Holding Co Ltd | Certificate Issued | 2009-07-31 | view |
| CXHB0801682 | 注射用对甲苯磺酸二硫酸腺苷蛋氨酸 | Ademetionine disulfate tosylate | Lyophilized | Chemical Drugs | Supplementary Application | 2009-03-02 | 北京凯因科技股份有限公司 | Beijing Kawin Technology Share-Holding Co Ltd | Certificate Issued | 2009-07-31 | view |
| CXHB0801684 | 对甲苯磺酸二硫酸腺苷蛋氨酸 | Ademetionine disulfate tosylate | Active ingredient | Chemical Drugs | Supplementary Application | 2009-04-03 | 北京凯因科技股份有限公司 | Beijing Kawin Technology Share-Holding Co Ltd | Certificate Issued | 2009-12-07 | view |
| CXHL1401836 | KW-136 | coblopasvir hydrochloride | Active ingredient | Chemical Drugs(1.1) | New Drug Application | 2015-01-04 | 北京凯因科技股份有限公司 | Beijing Kawin Technology Share-Holding Co Ltd | Certificate Issued | 2016-05-05 | view |
| CXHL1401837 | KW-136胶囊 | coblopasvir hydrochloride | Capsule | Chemical Drugs(1.1) | New Drug Application | 2015-01-04 | 北京凯因科技股份有限公司 | Beijing Kawin Technology Share-Holding Co Ltd | Certificate Issued | 2016-05-05 | view |
| CXHL1401838 | KW-136胶囊 | coblopasvir hydrochloride | Capsule | Chemical Drugs(1.1) | New Drug Application | 2015-01-04 | 北京凯因科技股份有限公司 | Beijing Kawin Technology Share-Holding Co Ltd | Certificate Issued | 2016-05-05 | view |
| CXHL1600290 | KW-136片 | coblopasvir hydrochloride | Tablet | Chemical Drugs(1) | New Drug Application | 2017-04-13 | 北京凯因科技股份有限公司 | Beijing Kawin Technology Share-Holding Co Ltd | Certificate Issued | 2017-11-30 | view |
| CXHL1600291 | KW-136片 | coblopasvir hydrochloride | Tablet | Chemical Drugs(1) | New Drug Application | 2017-04-13 | 北京凯因科技股份有限公司 | Beijing Kawin Technology Share-Holding Co Ltd | Certificate Issued | 2017-11-30 | view |
| CXHL2500463 | KW-040注射液 | KW-040 | Injection | Chemical Drugs(1) | New Drug Application | 2025-05-14 | | Beijing Kawin Technology Share-Holding Co Ltd | | | view |
| CXHS1400042 | 吡非尼酮片 | pirfenidone | Tablet | Chemical Drugs(3.1) | New Drug Application | 2014-06-27 | 北京凯因科技股份有限公司 | Beijing Kawin Technology Share-Holding Co Ltd | Certificate Issued | 2016-01-21 | view |
| CXHS1800007 | KW-136胶囊 | coblopasvir hydrochloride | Capsule | Chemical Drugs(1) | New Drug Application | 2018-06-22 | 北京凯因科技股份有限公司 | Beijing Kawin Technology Share-Holding Co Ltd;Beijing Kaiyingeling Biotechnology Co Ltd | Certificate Issued | 2020-02-14 | view |
| CXSB2300020 | 培集成干扰素α-2注射液 | peginterferon alfacon-2 | Injection | Biological Products | Supplementary Application | 2023-02-25 | | Beijing Kawin Technology Share-Holding Co Ltd | | | view |
| CXSL1400125 | 注射用重组人白细胞介素15 | | Lyophilized | Biological Products(1) | New Drug Application | 2015-01-19 | 北京凯因科技股份有限公司 | Beijing Kawin Technology Share-Holding Co Ltd | Certificate Issued | 2016-11-09 | view |
| CXSL2000361 | XW003注射液 | ecnoglutide | Injection | Biological Products(1) | New Drug Application | 2020-12-16 | 杭州先为达生物科技有限公司；北京凯因科技股份有限公司 | Hang Zhou Sciwind Biosciences Co Ltd | In Review | 2020-12-15 | view |
| CXSL2200459 | 人干扰素α2b喷雾剂 | Recombinant Human Interferon α2b | Spray | Biological Products(2.2) | New Drug Application | 2022-09-14 | | Beijing Kawin Technology Share-Holding Co Ltd | | | view |
| CXSL2200464 | 培集成干扰素α-2注射液 | peginterferon alfacon-2 | Injection | Biological Products(2.2) | New Drug Application | 2022-09-16 | | Beijing Kawin Technology Share-Holding Co Ltd | | | view |
| CXSL2300038 | KW-027注射液 | KW-027 | Injection | Biological Products(1) | New Drug Application | 2023-01-13 | | Beijing Kawin Technology Share-Holding Co Ltd | | | view |
| CXSL2300345 | 培集成干扰素α-2注射液 | peginterferon alfacon-2 | Injection | Biological Products(2.2) | New Drug Application | 2023-05-17 | | Beijing Kawin Technology Share-Holding Co Ltd | | | view |
| CXSL2400016 | 人干扰素α2b阴道泡腾片 | Recombinant Human Interferon α2b | Tablet | Biological Products(2.2) | New Drug Application | 2024-01-09 | | Beijing Kawin Technology Share-Holding Co Ltd | | | view |
| CXSL2400018 | 人干扰素α2b阴道泡腾片 | Recombinant Human Interferon α2b | Tablet | Biological Products(2.2) | New Drug Application | 2024-01-10 | | Beijing Kawin Technology Share-Holding Co Ltd | | | view |
